SG28347G - Novel morpholinol compounds their preparation and use - Google Patents

Novel morpholinol compounds their preparation and use

Info

Publication number
SG28347G
SG28347G SG1995904223A SG1995904223A SG28347G SG 28347 G SG28347 G SG 28347G SG 1995904223 A SG1995904223 A SG 1995904223A SG 1995904223 A SG1995904223 A SG 1995904223A SG 28347 G SG28347 G SG 28347G
Authority
SG
Singapore
Prior art keywords
novel
compounds
morpholinol
preparation
carbon atoms
Prior art date
Application number
SG1995904223A
Other languages
English (en)
Inventor
James Leroy Kelley
David Lee Musso
Grady Evan Boswell
Barrett Randolph Cooper
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SG28347G publication Critical patent/SG28347G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1995904223A 1989-10-31 1990-10-30 Novel morpholinol compounds their preparation and use SG28347G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924528A GB8924528D0 (en) 1989-10-31 1989-10-31 Heterocyclic pharmaceutical compounds,preparation and use

Publications (1)

Publication Number Publication Date
SG28347G true SG28347G (en) 1995-09-18

Family

ID=10665482

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995904223A SG28347G (en) 1989-10-31 1990-10-30 Novel morpholinol compounds their preparation and use

Country Status (19)

Country Link
US (1) US5104870A (ja)
EP (1) EP0426416B1 (ja)
JP (1) JP2873076B2 (ja)
AT (1) ATE101604T1 (ja)
AU (1) AU645763B2 (ja)
CA (1) CA2028893C (ja)
DE (1) DE69006682T2 (ja)
DK (1) DK0426416T3 (ja)
ES (1) ES2062406T3 (ja)
FI (1) FI94753C (ja)
GB (1) GB8924528D0 (ja)
HU (2) HU207304B (ja)
IE (1) IE66115B1 (ja)
LV (1) LV11030B (ja)
MX (1) MX9203219A (ja)
NZ (1) NZ235882A (ja)
PT (1) PT95735B (ja)
SG (1) SG28347G (ja)
ZA (1) ZA908696B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
AU1403899A (en) * 1997-11-14 1999-06-07 Glaxo Group Limited Method of treating addiction to nicotine products
MA26693A1 (fr) * 1998-09-28 2004-12-20 Glaxo Group Ltd Compositions pour administration par voie buccale
AU7750100A (en) * 1999-10-13 2001-04-23 Glaxo Group Limited Method for the treatment of obesity
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
CA2635261A1 (en) * 2006-01-03 2007-07-12 Algebra, Inc. Therapeutic amine-arylsulfonamide conjugate compounds
EP2419400A1 (en) 2009-04-15 2012-02-22 Research Triangle Institute Monoamine reuptake inhibitors
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体
JP5952267B2 (ja) * 2010-05-21 2016-07-13 リサーチ・トライアングル・インスティチュート 薬物依存を処置するためのヒドロキシブプロピオン類似体(政府支援研究または開発)
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds

Also Published As

Publication number Publication date
PT95735A (pt) 1991-09-13
PT95735B (pt) 1998-01-30
MX9203219A (es) 1992-07-01
EP0426416A1 (en) 1991-05-08
AU6563990A (en) 1991-05-09
HU207304B (en) 1993-03-29
GB8924528D0 (en) 1989-12-20
LV11030B (en) 1996-08-20
JP2873076B2 (ja) 1999-03-24
DK0426416T3 (da) 1994-03-14
FI94753B (fi) 1995-07-14
AU645763B2 (en) 1994-01-27
IE903888A1 (en) 1991-05-08
FI94753C (fi) 1995-10-25
JPH03206084A (ja) 1991-09-09
IE66115B1 (en) 1995-12-13
CA2028893A1 (en) 1991-05-01
HUT57748A (en) 1991-12-30
ATE101604T1 (de) 1994-03-15
ZA908696B (en) 1992-07-29
HU906935D0 (en) 1991-05-28
US5104870A (en) 1992-04-14
DE69006682D1 (de) 1994-03-24
ES2062406T3 (es) 1994-12-16
HU211304A9 (en) 1995-11-28
EP0426416B1 (en) 1994-02-16
NZ235882A (en) 1993-05-26
LV11030A (lv) 1996-02-20
DE69006682T2 (de) 1994-08-04
CA2028893C (en) 2000-10-10
FI905356A0 (fi) 1990-10-30

Similar Documents

Publication Publication Date Title
IE883662L (en) Compounds
ZA897660B (en) Biologically active compounds
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
SG28347G (en) Novel morpholinol compounds their preparation and use
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
CA2108967A1 (en) Arylmorpholine, preparation and use
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
NO158677C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater.
EP0259707A3 (en) Hydroxybutenolide derivatives, production and use thereof
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
HUT49283A (en) Process for production of medical compositions applicable for treatment of peptical ulcer
DE3768516D1 (de) Chinonamide, deren herstellung und anwendung.
GR3005131T3 (ja)
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
IL86136A (en) Thiadiazole guanidines,process for preparation thereof and pharmaceutical compositions containing the same